Human Reproduction Lab and IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Affiliated to Tel Aviv University, Sackler Faculty of Medicine, Tel-Hashomer, Ramat Gan, Israel.
IVF unit, Shamir Medical center (Assaf Hrofeh), Affiliated to Tel Aviv University, Sackler Faculty of Medicine, Tel-Aviv, Israel.
J Ovarian Res. 2020 Feb 10;13(1):15. doi: 10.1186/s13048-020-0612-3.
DCN (decorin) is a proteoglycan known to be involved in regulating cell proliferation, collagen fibril organization and migration. In our global transcriptome RNA-sequencing approach to systematically identify new ovulation-associated genes, DCN was identified as one of the highly regulated genes. We therefore hypothesize that DCN may have a role in ovulatory processes such as cell migration and proliferation.
To characterize the expression, regulation and function of the proteoglycan DCN in the human ovarian follicles during the preovulatory period.
The in-vivo expression of DCN mRNA in mural (MGCs) and cumulus (CGCs) granulosa cells was characterized using quantitative RT-PCR and western blot. A signaling study was performed by treating human MGCs cultures with gonadotropins and different stimulators and inhibitors to determine their effect on DCN expression by qRT- PCR and elucidate the pathways regulating these proteins. In a functional study, KGN granulosa cell line was used to study cell migration with a scratch assay.
DCN mRNA expression was significantly higher in MGCs compared to CGCs. DCN mRNA was significantly higher in CGCs surrounding mature metaphase II (MII) oocytes compared to CGCs of germinal vesicle (GV) and metaphase I (MI) oocytes. hCG significantly increased DCN mRNA and protein expression levels in cultured MGCs. Using signal transduction activators and inhibitors, we demonstrated that DCN induction by LH/hCG is carried out via PKA, PKC, ERK/MEK, and PI3K pathways. We showed that DCN expression is also induced in high-density cell cultures, in a dose-dependent pattern. In addition, progesterone induced a significant increase in DCN secretion to the media. MGCs from follicles of endometriosis patients exhibited reduced (about 20% of) mRNA transcriptions levels compared to MGCs follicles of control patients. More significantly, we found that DCN has an inhibiting effect on KGN cell migration.
Our study indicates that DCN is a unique ovulatory gene. Our findings support the hypothesis that DCN plays an important new role during the preovulatory period and ovulation, and stress its involvement in endometriosis infertility. A better understanding of DCN role in ovulation and endometriosis may provide treatment for some types of infertility.
DCN(饰胶蛋白)是一种已知参与调节细胞增殖、胶原纤维组织和迁移的蛋白聚糖。在我们系统地鉴定新排卵相关基因的全球转录组 RNA 测序方法中,DCN 被鉴定为高度调控基因之一。因此,我们假设 DCN 可能在排卵过程中发挥作用,如细胞迁移和增殖。
描述在人类卵巢滤泡的预排卵期间,蛋白聚糖 DCN 在其中的表达、调控和功能。
使用定量 RT-PCR 和 Western blot 技术研究壁层(MGCs)和颗粒细胞(CGCs)中 DCN mRNA 的体内表达。通过用促性腺激素和不同的刺激剂和抑制剂处理人 MGCs 培养物来进行信号研究,以通过 qRT-PCR 确定它们对 DCN 表达的影响,并阐明调节这些蛋白的途径。在功能研究中,使用 KGN 颗粒细胞系通过划痕实验研究细胞迁移。
与 CGCs 相比,MGCs 中的 DCN mRNA 表达明显更高。与 GV 和 MI 卵母细胞的 CGCs 相比,成熟中期 II(MII)卵母细胞周围的 CGCs 中 DCN mRNA 表达明显更高。hCG 显著增加了培养的 MGCs 中 DCN mRNA 和蛋白表达水平。使用信号转导激活剂和抑制剂,我们证明了 LH/hCG 诱导的 DCN 诱导是通过 PKA、PKC、ERK/MEK 和 PI3K 途径进行的。我们表明,DCN 表达也在高细胞密度培养物中以剂量依赖性方式诱导。此外,孕激素诱导 DCN 分泌到培养基中的显著增加。与对照患者的卵泡相比,子宫内膜异位症患者的卵泡中 MGCs 的 mRNA 转录水平降低(约 20%)。更重要的是,我们发现 DCN 对 KGN 细胞迁移具有抑制作用。
我们的研究表明 DCN 是一种独特的排卵基因。我们的研究结果支持 DCN 在预排卵期间和排卵中发挥重要新作用的假设,并强调其参与子宫内膜异位症不孕。对 DCN 在排卵和子宫内膜异位症中的作用的更好理解可能为某些类型的不孕提供治疗方法。